With you every step of your cell & gene therapy journey
Discover comprehensive products, testing, and CDMO solutions for your cell and gene therapy
Visit Us at ASGCT
May 13-17, Booth #1237
Developing gene therapies demands specialized expertise that is distinct from traditional biologics. Our deep understanding of viral vector manufacturing processes, coupled with our state-of-the-art viral vector CDMO facility and tailored testing capabilities addresses the unique challenges of this modality, ensuring the success of your cell or gene therapy candidates. From process improvements and accelerating timelines to regulatory support, we provide the right solutions to help you achieve success.
Viral Vector Upstream Production Platforms
Are you at the stage where you need to develop your upstream process? Discover how our upstream platforms together with our experienced technology and regulatory teams, can help you optimize your viral vector process to maximize your titer, setting the stage for better downstream production and timelines.
Contact our viral vector production team to schedule a meeting during ASGCT.
Viral Vector CDMO Services
Are you ready to partner with a CDMO to support your development, manufacturing, and fill/finish needs? Backed by 30+ years of viral vector development and manufacturing experience and a superior regulatory track record, we have supported 4 commercially approved cell & gene therapies from pre-IND through routine supply. Connect with our team of experts to discover how our end-to-end CDMO solutions can accelerate your therapeutic from preclinical through commercial production.
Contact our CDMO team to schedule a meeting during ASGCT.
Contract Testing Services
Or are you seeking an expert partner for gene therapy characterization and release testing? With 75+ years of scientific and regulatory expertise in biosafety testing, be sure to stop by and meet our team who are eager to discuss with you how our comprehensive testing solutions can meet your needs and support your project’s success.
Contact our Contract Testing Services team to schedule a meeting during ASGCT.
Presentations
Optimizing AAV gene therapies: NGS applications to enhance development, manufacturing, and testing
Wednesday, May 14th, 8:00 - 8:30 AM
Room 271-273
Harnessing Innovative Technologies for Enhancing AAV Production
Wednesday, May 14th, 2:00 – 2:15 PM
Tools and Technology Forum
To 1000L and Beyond: Introducing the first-and-only transfection complex stabilizer for simple AAV manufacturing scale-up
Friday, May 16th, 8:30 – 9:00 AM
Room 383-385
Oral Abstracts
Enhanced AAV Capture Using Membrane Chromatography and Optimized Mid-Stream Processing
Thursday, May 15th, 4:45 - 5:00 PM
NOLA Theater C
Breaking Boundaries in AAV Production: Exploiting High Salt Concentrations for increased AAV yields and infectivity, Kim Schrag
Saturday, May 17th – 8:45 – 9:00 am
Room 388-390
Posters - Hall I2
Tuesday, May 13th – 6:00 – 7:30 pm
- Increasing rAAV productivity through selection of a high producing HEK293 transient cell line and addition of an enhancer
Sonal Patel - A Scalable, DoE-based Approach to Improving Plasmid Ratios for AAV Transfection
Frank Fabian, Ph.D.
Wednesday, May 14th – 5:30 – 7:00 pm
- Methods to Improve the Clarification Process of AAV Therapy Manufacturing
Philip Szymanski - Affinity purification analysis: a comparison of AAV2 and AAV5 serotypes
Smriti Mishra, Ph.D. - Next-Generation Sequencing for AAV Characterization
Kelly Rios, Ph.D. - Multiplex ddPCR Approach as Proof-of-Principle for Accurate AAV Genome Integrity Assessment and Enhanced Vector Production
Ricardo Correa, Ph.D. - Strategies for residual DNA Clearance in Adeno-associated Virus (AAV) purification process
Akshat Gupta - Improving Precision and Specificity of CRISPR Gene Editing with RGEN-seq and RGEN-mod
Alexander Kuzin
Thursday, May 15th – 5:30 – 7:00 pm
- Strategies for Overcoming Analytical Challenges in Complex Upstream AAV Samples
Aparajita Chatterjee - Importance of AAV sample preparation for gc/mL titer determination using PCR
Agnieszka (Aga) Lass-Napiorkowska, Ph.D. - Utilization of Real-time Multi-angle Light Scattering (RT-MALS) for Accelerated AAV Chromatography Development
Samit Dutta, Ph.D. - High-Throughput Flow Cytometry Assay for Quantifying Infectivity of AAV, Adenovirus, and Lentivirus Vectors in Gene Therapy Applications
Tahsin Jahan - Optimizing Upstream Process Inputs to Enhance Viral Yields and Ensure Product Quality in Adeno-Associated Virus (AAV) Manufacturing
Megan Del Greco - Process Optimization of a Baculovirus-Insect Cell Expression System for Scalable rAAV Production
Megan Del Greco - RGENtool - a CRISPR/Cas double-strand cleavage evaluator
Haiwang Yang, Ph.D. - Using Next Generation Sequencing to Test Raw Materials used in Biologics Manufacturing
Brianna McManus
Meet us there
ASGCT 2025
Ernest N. Morial Convention Center
Booth: 1237
New Orleans, United States
To continue reading please sign in or create an account.
Don't Have An Account?